跳至主要内容
临床试验/NCT04566874
NCT04566874Unknown不适用

SPIRA™-A 3D Printed Titanium Anterior Lumbar Interbody Fusion Device and HCT/p Demineralized Bone Matrix Versus Medtronic Divergent™-L/Perimeter™ PEEK Anterior Lumbar Interbody Fusion Device and Recombinant Bone Morphogenic Protein-2

Camber Spine Technologies4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年7月13日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
4
主要终点
Radiographic Fusion

研究概览

简要总结

A prospective, randomized, controlled clinical evaluation utilizing the SPIRA™ ALIF 3-D printed titanium interbody device with DBM vs a Medtronic PEEK ALIF interbody device with BMP

详细描述

This is a single blinded randomized 1:1, controlled, prospective clinical study to evaluate fusion status and patient reported outcomes in circumferential lumbar fusion between L2-S1 at a single level with posterior screw fixation (Camber Spine Orthros System) and anterior surgery consisting of one of the treatment groups: subjects treated with the SPIRA™-A Interbody Device and HCTP/p DBM or subjects treated with Medtronic Divergent-L or Perimeter™ PEEK ALIF Interbody Device and rhBMP-2 (6mg per level).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

subjects will be blinded prior to surgery. Following surgery, maintaining masking may not be feasible as subjects will have access to medical records and/or radiographs.

入排标准

年龄范围
22 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • skeletally mature adults
  • completed 6 month non-operative or conservative therapy
  • signed informed consent
  • back pain with radicular symptoms as evidenced by leg pain
  • Degenerative Disc Disease involving a single level between L2 and S1
  • subject willing to participate in study and follow protocol
  • subject willing to comply with Post-op management program

排除标准

  • systemic infection such as AIDS, HIV or Active hepatitis
  • autoimmune disease
  • significant metabolic disease that might compromise bone growth
  • history of malignancy
  • previous surgery for primary tumor, trauma or infection
  • subject requires 2 or more levels of fusion
  • previous spinal instrumentation or previous interbody fusion at involved level
  • spondylolisthesis of grade greater than/equal to 2

结局指标

主要结局

Radiographic Fusion

时间窗: 24 months

AP/Lateral, Flexion, Extension and CT radiographs

次要结局

  • Back and Leg VAS(up to and including 24 months)
  • Oswestry Disability Index(up to and including 24 months)
  • VR-12 Health Survey(up to and including 24 months)
  • PROMIS score(up to and including 24 months)

研究者

发起方
Camber Spine Technologies
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验